Austrianova Biomanufacturing

Austrianova is a biotechnology company specializing in the encapsulation of living cells and microorganisms using its proprietary "Cell-in-a-Box" and "Bac-in-a-Box" technologies. These platforms utilize a cellulose-based material to protect encapsulated cells from the host's immune system while allowing for the diffusion of nutrients and therapeutic proteins. The company operates as a technology provider and Contract Development and Manufacturing Organization (CDMO), offering GMP-compliant manufacturing services for cell-based therapies. Its lead applications include localized chemotherapy activation for pancreatic cancer and the delivery of insulin-producing cells for diabetes. Austrianova is headquartered in Singapore and maintains specialized manufacturing facilities in Thailand to support global clinical and commercial needs.